Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Shares Outstanding (Diluted Average): 2012-2025

Historic Shares Outstanding (Diluted Average) for Ascendis Pharma A (ASND) over the last 4 years, with Jun 2025 value amounting to $6.7 million.

  • Ascendis Pharma A's Shares Outstanding (Diluted Average) rose 1.77% to $6.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.7 million, marking a year-over-year increase of 1.77%. This contributed to the annual value of $7.0 million for FY2023, which is 0.23% up from last year.
  • As of Q2 2025, Ascendis Pharma A's Shares Outstanding (Diluted Average) stood at $6.7 million, which was up 1.77% from $6.6 million recorded in Q2 2024.
  • Ascendis Pharma A's 5-year Shares Outstanding (Diluted Average) high stood at $8.1 million for Q4 2021, and its period low was $6.6 million during Q2 2024.
  • Over the past 3 years, Ascendis Pharma A's median Shares Outstanding (Diluted Average) value was $6.7 million (recorded in 2025), while the average stood at $6.8 million.
  • As far as peak fluctuations go, Ascendis Pharma A's Shares Outstanding (Diluted Average) rose by 10.57% in 2021, and later decreased by 13.60% in 2022.
  • Over the past 5 years, Ascendis Pharma A's Shares Outstanding (Diluted Average) (Quarterly) stood at $8.1 million in 2021, then declined by 13.60% to $7.0 million in 2022, then grew by 0.23% to $7.0 million in 2023, then reached $6.6 million in 2024, then increased by 1.77% to $6.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $6.7 million for Q2 2025, versus $6.6 million for Q2 2024 and $7.0 million for Q4 2023.